Articular cartilage does not contain blood vessels. It has no vascular supply of its own and is nourished exclusively through diffusion (self-movement) from the synovial fluid and the subchondral bone.

This means:

• no delivery of stem cells from the blood to the site of the injury,
• no fibroblasts or repair cells, which normally migrate from blood vessels,
• very slow transport of nutrients and repair signals.

By comparison, bone, which is vascularized, regenerates efficiently. Cartilage does not.

Cartilage does not hurt until the damage reaches the subchondral bone or the synovial membrane. This also means there is an absence of local nerve signals, which normally coordinate repair processes in other tissues.

Mature chondrocytes barely divide. Once cells are lost at the injury site, there is no source for new ones – the local population is too small and too inactive to fill the defect. Additionally, chondrocyte density naturally declines with age (it is many times higher in a newborn than in a 60-year-old).

The cartilage matrix contains active inhibitors of angiogenesis and cell proliferation (such as chondromodulin and thrombospondin). This makes evolutionary sense—cartilage must remain mechanically stable, so its remodeling is intentionally suppressed. Unfortunately, these same inhibitors block regeneration after an injury.

A chronic inflammatory state, mechanical trauma, or a drop in estrogen levels is enough to tip the scale toward catabolism (breakdown), and cartilage begins to deplete faster than it can be rebuilt.

When deep damage occurs and reaches the bone, the body attempts to repair the defect but fills it with fibrocartilage, which is rich in type I collagen instead of type II. Fibrocartilage is:

• mechanically weaker,
• less elastic,
• prone to faster wear and tear.

This is not true regeneration—it is a lower-quality substitute.

Supplementing type II collagen within the context of limited joint regeneration has scientific justification based on two main mechanisms: the stimulation of biosynthesis and the modulation of the immune response. Because cartilage tissue has no direct access to blood vessels, delivering this ingredient does not work by simply “filling in” physical gaps, but rather relies on triggering specific cellular signals.

In the case of native type II collagen:

• The mechanism of oral tolerance is crucial, occurring in the lymphoid tissue of the digestive tract, specifically in Peyer’s patches.
• The intact triple helix structure of this protein is not treated as mere building material, but as information for the immune system.
• Immune cells in the intestines recognize this structure and stimulate the production of regulatory T cells (Tregs), which then migrate to the joint areas.
• Once there, their role is to dampen the local inflammatory response and inhibit the activity of enzymes responsible for destroying the natural joint structure.

This is of fundamental importance because chronic inflammation drastically shifts the tissue’s metabolic balance toward catabolism, accelerating the degradation of the extracellular matrix.

By effectively shutting down these destructive processes, native collagen prevents the formation of deep defects that reach the subchondral bone. In this way, it protects the joint from a situation where the body -deprived of efficient repair mechanisms and vascularity – would be forced to fill the damage with mechanically weaker fibrocartilage dominated by type I collagen.

Consequently, this type of supplementation provides targeted biochemical support that stabilizes joint structure in an environment lacking natural, rapid self-regeneration.

UC-II® is one of the most interesting substances in joint supplementation. In terms of its mechanism of action, it is completely unique and differs fundamentally from collagen hydrolysate, glucosamine, or chondroitin.

UC-II® is a patented, undenatured (native) collagen derived from chicken sternum cartilage, extensively researched for its ability to support articular cartilage and reduce inflammation.

The key word here is “undenatured” because the collagen retains its native triple helix structure. It is this precise 3D spatial structure that is biologically active. Collagen hydrolysate (such as fish collagen powder) is broken down into peptides and works through a completely different mechanism.

Mechanism of Action and Cartilage Protection

UC-II® simultaneously reduces the activity of cartilage-degrading enzymes (MMP-1, MMP-3, MMP-13) and inflammatory mediators (NO, PGE₂). By doing so, it alleviates:

• synovial membrane inflammation,

• oxidative stress,

• neutrophil infiltration.

At the same time, it maintains synovial fluid stability and the integrity of the cartilage extracellular matrix (ECM). Cartilage preservation and an increase in chondrocyte count directly correlate with a reduction in MMP-13 protein levels and decreased cell apoptosis (programmed cell death).

Clinical Trial: UC-II® vs. Glucosamine + Chondroitin

In a multicenter, randomized, double-blind, placebo-controlled study, 191 volunteers were randomly assigned to three groups for 180 days: UC-II® (40 mg/day), glucosamine + chondroitin (1500 mg + 1200 mg/day), or placebo.

Results after 180 days:

UC-II® significantly outperformed the glucosamine and chondroitin combination across all clinical metrics. Reductions in pain and stiffness were observed as early as 30 days into supplementation.

Translating these indexes into everyday practice:

• WOMAC measures overall pain, stiffness, and difficulties in physical daily activities.

• VAS focuses exclusively on the intensity of the pain itself.

• Lequesne index determines the degree of mobility limitation and the maximum distance a patient is able to walk.

Study in Healthy, Physically Active Individuals

The ability to modulate immunity through the ingestion of a food or antigen is called oral tolerance. This is an ongoing, normal physiological process that protects the digestive tract from unwanted immune damage. Several distinct types of regulatory T cells (Tregs) mediate this phenomenon by releasing anti-inflammatory cytokines, specifically IL-10 and TGF-β.

Crucially, research shows that this effect is temporary – it requires continuous ingestion of the antigen to maintain the tolerogenic state.

Important implication: UC-II® must be used regularly and continuously, as oral tolerance fades once supplementation is discontinued.

UC-II® vs. Collagen Hydrolysate – A Fundamental Difference

Both types of collagen can work synergistically, but they target the joints through completely different pathways:

Summary – Why UC-II® is Unique

Most joint supplements work from the outside in by supplying raw materials to build cartilage. UC-II® works from the inside out—it educates the immune system to stop destroying its own cartilage. This targeted approach is exceptionally valuable in addressing inflammatory states and the autoimmune components of both Osteoarthritis (OA) and Rheumatoid Arthritis (RA).